India To Centralize Drug, Device Purchases For Health Outlets
This article was originally published in PharmAsia News
Executive Summary
India's government plans to establish one place for government purchases of drugs and medical devices. The intention of the change is to provide greater transparency in government procurement of medicines for dispensaries and health-care centers. Currently, those buys are left to the centers themselves or to the state governments to buy the products they need. Under the new plan, a Medical Services Corp would be created as the central Indian government agency to buy drugs and devices. (Click here for moreYou may also be interested in...
QUOTED. 13 December 2019. Todd Garner
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Sarepta Scores Another Remarkable Approval With Vyondys 53 For Duchenne
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Real-World Evidence Fails Another Test At US FDA
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports